Cas:82611-85-6 ALPS manufacturer & supplier

Chemical Name:ALPS

CAS.NO:82611-85-6

Synonyms:ALPS;potassium 3-[ethyl(phenyl)amino]propane-1-sulfonate;3-(N-Ethylanilino)propanesulfonic Acid Sodium Salt;MFCD01311047;Sodium 3-[ethyl(phenyl)amino]-1-propanesulfonate;S0817;V1289;N-Ethyl-N-(3-sulfopropyl)aniline Sodium Salt;1-Propanesulfonic acid, 3-(ethylphenylamino)-, sodium salt (1:1);N-ETHYL-N-(3-SULFOPROPYL)ANILINE;Sodium 3-(N-Ethylanilino)propanesulfonate

Molecular Formula:C₁₁H₁₆NNaO₃S

Molecular Weight:265.304

HS Code:

Physical and Chemical Properties:

Melting point:265 °C (dec.)(lit.)

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:68.82000

Exact Mass:265.074860

LogP:2.52900

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ALPS chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sodium 3-(N-Ethylanilino)propanesulfonate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Propanesulfonic acid, 3-(ethylphenylamino)-, sodium salt (1:1) Use and application,ALPS technical grade,usp/ep/jp grade.

Related News: Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” 6-chloro-N-(5-isopropoxy-7-(2-(piperidin-1-yl)ethoxy)quinazolin-4-yl)-[1,3]dioxolo[4,5-b]pyridin-7-amine manufacturers The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities. 3-carboxy-2-formyl-4,5,6,7-tetrahydrobenzothiene suppliers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. 5-amino-6-chloro-2-methyl-N-({1-[2-(1-methylcyclopropyl)-2-oxoethyl]piperidin-4-yl}methyl)imidazo[1,2-a]pyridine-8-carboxamide vendor & factory.